TY - JOUR
T1 - Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016
AU - Committee for Clinical Practice Guidelines for the Management of Atopic Dermatitis of Japanese Dermatological Association
AU - Saeki, Hidehisa
AU - Nakahara, Takeshi
AU - Tanaka, Akio
AU - Kabashima, Kenji
AU - Sugaya, Makoto
AU - Murota, Hiroyuki
AU - Ebihara, Tamotsu
AU - Kataoka, Yoko
AU - Aihara, Michiko
AU - Etoh, Takafumi
AU - Katoh, Norito
N1 - Funding Information:
For the development of these guidelines, valuable guidance and advice on food allergy UV therapy, and methodology of guideline preparation were provided by Doctor Yukihiro Ohya, Director of the Department of Allergy, the National Center for Child Health and Development, Professor Akimichi Morita of the Faculty of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, and Doctor Hiroshi Koga, Department of Dermatology, Shinshu University, respectively. We take this opportunity to thank them. We would also like to express our sincere gratitude to members of the Authorized Nonprofit Organization Japan Allergy Tomono Kai for their cooperation with the setting of clinical questions. We also thank Doctors Koji Masuda and Risa Mineoka of the Department of Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science for their clerical work at the Secretariat.
Publisher Copyright:
© 2016 Japanese Dermatological Association
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. Most patients have an atopic predisposition. The definitive diagnosis of AD requires the presence of all three features: (i) pruritus; (ii) typical morphology and distribution of the eczema; and (iii) chronic and chronically relapsing course. The current strategies to treat AD in Japan from the perspective of evidence-based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity-related patient outcomes with respect to several important points requiring decision-making in clinical practice.
AB - Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. Most patients have an atopic predisposition. The definitive diagnosis of AD requires the presence of all three features: (i) pruritus; (ii) typical morphology and distribution of the eczema; and (iii) chronic and chronically relapsing course. The current strategies to treat AD in Japan from the perspective of evidence-based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity-related patient outcomes with respect to several important points requiring decision-making in clinical practice.
KW - atopic dermatitis
KW - clinical practice guideline
KW - diagnosis
KW - evidence-based medicine
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=84963858661&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84963858661&partnerID=8YFLogxK
U2 - 10.1111/1346-8138.13392
DO - 10.1111/1346-8138.13392
M3 - Article
C2 - 27076388
AN - SCOPUS:84963858661
SN - 0385-2407
VL - 43
SP - 1117
EP - 1145
JO - Journal of Dermatology
JF - Journal of Dermatology
IS - 10
ER -